O00408 (PDE2A_HUMAN) Homo sapiens (Human)

cGMP-dependent 3',5'-cyclic phosphodiesterase UniProtKBInterProSTRINGInteractive Modelling

941 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5; Isoform 6; ) Identical sequences: Pan troglodytes: A0A6D2W1U4; H2R546; Pan paniscus: A0A2R9BH84

Sequence Features

 656Proton donor
 660Divalent metal cation 1
 696Divalent metal cation 1
 697Divalent metal cation 1
 697Divalent metal cation 2
 808Divalent metal cation 1
 224T -> I (in dbSNP:rs341047) VAR_024170 dbSNP
 241-371GAF domain
IPR003018PF13185
 409-548GAF domain
IPR003018PF01590
 655-8883'5'-cyclic nucleotide phosphodiesterase, catalytic domain
IPR002073PF00233

Sequence Alignments

Experimental structures

DescriptionOligo-stateLigandsStructureRangeDownloadAssess
Crystal structure of of PDE2-inhibitor complexhomo-4-mer ZN;MG;1L6;4jib579-916
X-ray structure of PDE2Ahomo-2-mer ZN;MG;3ibj223-900
Crystal structure of human phosphodiesterase 2A in complex with 6-methyl-N-(1-(4-(trifluoromethoxy)…homo-2-mer MG;ZN;87R;5xkm579-918
hPDE2A catalytic domain complexed with IBMXhomo-2-mer ZN;MG;IBM;3itu579-916
Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4-(trifluoromethoxy)phenyl]-2-methoxyethyl}-7-m…homo-2-mer ZN;MG;9GA;5vp1579-916
Crystal structure of PDE2 catalytic domain in complex with BAY60-7550homo-2-mer ZN;MG;19F;4htx579-916
Crystal structure of PDE2 catalytic domain in space group P1homo-2-mer ZN;MG;4htz579-916
PDE2 in complex with compound 5homo-2-mer ZN;MG;FKJ; 11×EDO;6cyc581-916
PDE2 in complex with compound 7homo-2-mer ZN;MG;EDO;FKV;6cyb581-916
PDE2 in complex with compound 7homo-2-mer ZN;MG;FKG;EDO;6cyd581-916
Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4-(trifluoromethoxy)phenyl]-2-methoxyethyl}-7-m…homo-2-mer ZN;MG;9GJ;5vp0583-916
Catalytic domain of hPDE2Ahomo-2-mer ZN;3itm579-901
PDE2 in complex with molecule 5monomer MG;ZN;C6Z;GOL;SO4;NA;6ezf580-919
The Crystal Structure of the Phosphodiesterase 2A Catalytic Domainmonomer ZN;MG;PO4;1z1l576-915
Crystal Structure of human PDE2a in complex with (5S)-1-[(3-bromo-4-fluorophenyl)carbonyl]-3,3-difl…monomer 7OJ;ZN;MG;5tzc579-918
PDE2a catalytic domain in complex with a brain penetrant inhibitormonomer 788;ZN;MG;4d09579-918
Crystal structure of human phosphodiesterase 2A with 1-(2-chlorophenyl)-N,4-dimethyl-[1,2,4]triazol…monomer EOG;ZN;MG;6c7e579-917
CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX WITH 1-[(3,4-difluorophenyl)carbonyl]-3,…monomer 7P4;ZN;MG;5tzw579-917
CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX WITH 1-[(3-bromo-4-fluorophenyl)carbonyl…monomer 7OJ;ZN;MG;5tzz579-917
Crystal structure of human phosphodiesterase 2A with 1-(2-chloro-5-methoxy-phenyl)-N-isobutyl-4-met…monomer EP7;ZN;MG;6c7i579-917
Crystal structure of human phosphodiesterase 2A with N-(1-adamantyl)-1-(2-chlorophenyl)-4-methyl-[1…monomer EOJ;ZN;MG;6c7d579-917
Crystal structure of human phosphodiesterase 2A with 1-(2-chloro-5-isobutoxy-phenyl)-N,4-dimethyl-[…monomer EOS;ZN;MG;6c7f579-917
Crystal structure of human phosphodiesterase 2A with 1-(5-tert-butoxy-2-chloro-phenyl)-N-isobutyl-4…monomer EPV;ZN;MG;6c7j579-917
CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX WITH 1-[(3-chloro-4-fluorophenyl)carbony…monomer 7OY;ZN;MG;5tzx579-917
PDE2a catalytic domain in complex with a brain penetrant inhibitormonomer ZN;Q2T;MG;4d08579-917
PDE2 catalytic domain complexed with inhibitorsmonomer 7Y4;ZN;MG;5u7l579-917
CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX WITH 3,3-difluoro-1-[(4-fluoro-3-iodophe…monomer 7OV;ZN;MG;5u00579-916
CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX WITH 3,3-difluoro-1-[(4-fluorophenyl)car…monomer 7OP;ZN;MG;5tzh579-916
Crystal structure of human phosphodiesterase 2A with N-(1-adamantyl)-1-(2-chloro-5-isobutoxy-phenyl…monomer EOY;ZN;MG;6c7g579-916
CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A WITH 3-{5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-…monomer 7OG;ZN;MG;5tza579-916
CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX with [1,2,4]triazolo[1,5-a]pyrimidin-7-y…monomer 7OM;ZN;MG;5tz3579-916
PDE2 catalytic domain complexed with inhibitorsmonomer 19F;ZN;MG;5u7d579-916
PDE2 catalytic domain complexed with inhibitorsmonomer 7XV;ZN;MG;5u7j579-916
PDE2 catalytic domain complexed with inhibitorsmonomer 7XS;ZN;MG;5u7i579-916
PDE2 catalytic domain complexed with inhibitorsmonomer ZN;MG;7Y1;5u7k579-916
PDE2 complexed with 2-[6-fluoro-8-methylsulfonyl-9-[(1R)-1-[4-(trifluoromethyl)phenyl]ethyl]-1,2,3,…monomer DY1;ZN;MG;6blf579-916
Crystal structure of PDE2 in complex with complex 9monomer ZN;MG;CZY;EDO;6b97582-916
Crystal Structure of PDE2 in complex with compound 16monomer ZN;MG;CZV;EDO;6b96582-916
PDE2 in complex with compound 1monomer ZN;MG;D07;6b98582-916
[1,2,4]Triazolo[1,5-a]pyrimidine Phosphodiesterase 2 Inhibitorsmonomer ZN;MG;QMZ;6znd591-916
Selective Inhibitors of PDE2, PDE9, and PDE10: Modulators of Activity of the Central Nervous Systemmonomer EH9;ZN;MG;4c1i581-905

Homology models

Oligo-stateLigandsQMEANTemplateRangeSeq id (%)DownloadAssess
monomer -3.931mc0.1.A44-388
19.81

Homology models built on isoform sequence

Isoform #Oligo-stateLigandsQMEANTemplateRangeSeq id (%)ReportDownloadAssess
3homo-2-merZN;MG;-2.443ibj.1.A216-893
100.00
4homo-2-merZN;MG;-2.443ibj.1.A214-891
100.00
2homo-2-merZN;MG;-2.443ibj.1.A202-879
100.00
6monomerPCG;-1.621mc0.1.A202-541
94.99
5monomerZN;MG;-3.153ibj.1.A102-644
100.00
5monomerZN;MG;-3.103ibj.1.A34-644
91.46
4monomerPCG;-1.601mc0.1.A214-553
94.99
2monomerPCG;-1.601mc0.1.A202-541
94.99
6homo-2-mer-2.873ibj.1.A202-728
100.00
3monomerPCG;-1.601mc0.1.A216-555
94.99
5monomerPCG;-2.291mc0.1.A35-306
80.78
4homo-2-mer-4.783ibj.1.A34-379
19.11
4monomer-3.961mc0.1.A35-378
18.91
2monomer-3.621mc0.1.A22-366
20.13
6monomer-3.741mc0.1.A22-367
20.06
3monomer-4.621mc0.1.A38-380
18.97